These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30267152)

  • 1. Morin decreases galectin-3 expression and sensitizes ovarian cancer cells to cisplatin.
    Bieg D; Sypniewski D; Nowak E; Bednarek I
    Arch Gynecol Obstet; 2018 Dec; 298(6):1181-1194. PubMed ID: 30267152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-424-3p suppresses galectin-3 expression and sensitizes ovarian cancer cells to cisplatin.
    Bieg D; Sypniewski D; Nowak E; Bednarek I
    Arch Gynecol Obstet; 2019 Apr; 299(4):1077-1087. PubMed ID: 30585294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morin Inhibits Ovarian Cancer Growth through the Inhibition of NF-κB Signaling Pathway.
    Xu M; Zhang Y
    Anticancer Agents Med Chem; 2019; 19(18):2243-2250. PubMed ID: 31660844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the CSF-1 receptor sensitizes ovarian cancer cells to cisplatin.
    Yu R; Jin H; Jin C; Huang X; Lin J; Teng Y
    Cell Biochem Funct; 2018 Mar; 36(2):80-87. PubMed ID: 29372560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A monoclonal antibody targeted against epidermal growth factor receptor variant III enhances cisplatin efficiency.
    Li N; Chu Y; Yao L; Ying X; Jiang H; Zhou M; Xu C
    J Cancer Res Clin Oncol; 2011 Oct; 137(10):1455-61. PubMed ID: 21809030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Luteolin sensitizes the antitumor effect of cisplatin in drug-resistant ovarian cancer via induction of apoptosis and inhibition of cell migration and invasion.
    Wang H; Luo Y; Qiao T; Wu Z; Huang Z
    J Ovarian Res; 2018 Nov; 11(1):93. PubMed ID: 30454003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms underlying the synergistic effect of SU5416 and cisplatin on cytotoxicity in human ovarian tumor cells.
    Zhong X; Li X; Wang G; Zhu Y; Hu G; Zhao J; Neace C; Ding H; Reed E; Li QQ
    Int J Oncol; 2004 Aug; 25(2):445-51. PubMed ID: 15254743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of Calycosin-7-O-β-D-Glucoside and its Synergistic Augmentation of Cisplatin-induced Apoptosis in SK-OV-3 Cells.
    Huang JZ; Li LL; Tan XY; Wu ZY; Chen DW; Luo X
    Curr Pharm Des; 2022; 28(26):2161-2166. PubMed ID: 35702792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galectin-3 regulates chemotherapy sensitivity in epithelial ovarian carcinoma via regulating mitochondrial function.
    Wang D; You D; Li L
    J Toxicol Sci; 2019; 44(1):47-56. PubMed ID: 30626779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valspodar-modulated chemotherapy in human ovarian cancer cells SK-OV-3 and MDAH-2774.
    Zalewski M; Kulbacka J; Saczko J; Drag-Zalesinska M; Choromanska A
    Bosn J Basic Med Sci; 2019 Aug; 19(3):234-241. PubMed ID: 30957724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alkaloids from Stephania venosa as Chemo-Sensitizers in SKOV3 Ovarian Cancer Cells via Akt/NF-κB Signaling.
    Mon MT; Yodkeeree S; Punfa W; Pompimon W; Limtrakul P
    Chem Pharm Bull (Tokyo); 2018; 66(2):162-169. PubMed ID: 29386467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the IGF signaling pathway reverses cisplatin resistance in ovarian cancer cells.
    Du J; Shi HR; Ren F; Wang JL; Wu QH; Li X; Zhang RT
    BMC Cancer; 2017 Dec; 17(1):851. PubMed ID: 29241458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukotriene B4 receptor-2 contributes to chemoresistance of SK-OV-3 ovarian cancer cells through activation of signal transducer and activator of transcription-3-linked cascade.
    Park J; Park SY; Kim JH
    Biochim Biophys Acta; 2016 Feb; 1863(2):236-43. PubMed ID: 26597704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathway overcomes cisplatin resistance in ovarian carcinoma cells.
    Nonaka M; Itamochi H; Kawaguchi W; Kudoh A; Sato S; Uegaki K; Naniwa J; Sato S; Shimada M; Oishi T; Terakawa N; Kigawa J; Harada T
    Int J Gynecol Cancer; 2012 Jul; 22(6):922-9. PubMed ID: 22672985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HO-3867, a curcumin analog, sensitizes cisplatin-resistant ovarian carcinoma, leading to therapeutic synergy through STAT3 inhibition.
    Selvendiran K; Ahmed S; Dayton A; Kuppusamy ML; Rivera BK; Kálai T; Hideg K; Kuppusamy P
    Cancer Biol Ther; 2011 Nov; 12(9):837-45. PubMed ID: 21885917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MircroRNA-139 sensitizes ovarian cancer cell to cisplatin-based chemotherapy through regulation of ATP7A/B.
    Xiao F; Li Y; Wan Y; Xue M
    Cancer Chemother Pharmacol; 2018 May; 81(5):935-947. PubMed ID: 29594361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-142-5p enhances cisplatin-induced apoptosis in ovarian cancer cells by targeting multiple anti-apoptotic genes.
    Li X; Chen W; Jin Y; Xue R; Su J; Mu Z; Li J; Jiang S
    Biochem Pharmacol; 2019 Mar; 161():98-112. PubMed ID: 30639456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic effects of the sesquiterpene lactone, EPD, with cisplatin and paclitaxel in ovarian cancer cells.
    van Haaften C; Boot A; Corver WE; van Eendenburg JD; Trimbos BJ; van Wezel T
    J Exp Clin Cancer Res; 2015 Apr; 34(1):38. PubMed ID: 25907439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LY2109761 enhances cisplatin antitumor activity in ovarian cancer cells.
    Gao Y; Shan N; Zhao C; Wang Y; Xu F; Li J; Yu X; Gao L; Yi Z
    Int J Clin Exp Pathol; 2015; 8(5):4923-32. PubMed ID: 26191185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the Nrf2-antioxidant system in cytotoxicity mediated by anticancer cisplatin: implication to cancer cell resistance.
    Cho JM; Manandhar S; Lee HR; Park HM; Kwak MK
    Cancer Lett; 2008 Feb; 260(1-2):96-108. PubMed ID: 18036733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.